Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
22
SBH Quote, Financials, Valuation and Earnings
Last price:
$10.84
Seasonality move
:
2.08%
Day range:
$11.00 - $11.36
52-week range:
$9.06 - $14.79
Dividend yield:
0%
P/E ratio:
7.76x
P/S ratio:
0.32x
P/B ratio:
1.81x
Volume:
1.7M
Avg. volume:
2.2M
1-year change:
-17.19%
Market cap:
$1.1B
Revenue:
$3.7B
EPS (TTM):
$1.44
Analysts' Opinion
-
Consensus RatingSally Beauty Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $12.00, Sally Beauty Holdings has an estimated upside of 30.59% from its current price of $11.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $11.18.
Fair Value
-
According to the consensus of 4 analysts, Sally Beauty Holdings has 30.59% upside to fair value with a price target of $12.00 per share.
SBH vs. S&P 500
-
Over the past 5 trading days, Sally Beauty Holdings has underperformed the S&P 500 by -9.39% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sally Beauty Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sally Beauty Holdings has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Sally Beauty Holdings reported revenues of $935M.
Earnings Growth
-
Sally Beauty Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Sally Beauty Holdings reported earnings per share of $0.46.
Enterprise value:
2B
EV / Invested capital:
1.25x
Price / LTM sales:
0.32x
EV / EBIT:
7.12x
EV / Revenue:
0.54x
PEG ratio (5yr expected):
10.53x
EV / Free cash flow:
13.85x
Price / Operating cash flow:
8.23x
Enterprise value / EBITDA:
5.13x
Gross Profit (TTM):
$1.9B
Return On Assets:
5.59%
Net Income Margin (TTM):
4.13%
Return On Equity:
27.33%
Return On Invested Capital:
9.59%
Operating Margin:
8.75%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $3.8B | $3.7B | $3.7B | $921.4M | $935M | |
| Gross Profit | $1.9B | $1.9B | $1.9B | $466.6M | $479.2M | |
| Operating Income | $365.2M | $342.2M | $282.7M | $76M | $81.8M | |
| EBITDA | $437.6M | $427.4M | $392.5M | $103.5M | $108.5M | |
| Diluted EPS | $1.65 | $1.68 | $1.44 | $0.39 | $0.46 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.4B | $1.1B | $1.2B | $1.3B | |
| Total Assets | $2.9B | $2.8B | $2.6B | $2.7B | $2.8B | |
| Current Liabilities | $563.4M | $664.9M | $667.9M | $579.3M | $592.7M | |
| Total Liabilities | $2.9B | $2.6B | $2.3B | $2.2B | $2.2B | |
| Total Equity | $15.4M | $280.7M | $293.6M | $508.7M | $628.5M | |
| Total Debt | $1.8B | $1.4B | $1.2B | $1.1B | $982.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $156.5M | $249.3M | $246.5M | $116.5M | $110.7M | |
| Cash From Investing | -$102.4M | -$99.8M | -$108.9M | -$36M | -$44.9M | |
| Cash From Financing | -$373.7M | -$100.8M | -$153.7M | -$32.6M | -$55.9M | |
| Free Cash Flow | $57.3M | $158.6M | $145.4M | $89.6M | $73.3M | |
SBH
Sector
Market Cap
$1.1B
$485.3M
Price % of 52-Week High
75.59%
72.99%
Dividend Yield
0%
0%
Shareholder Yield
5.86%
3.59%
1-Year Price Total Return
-17.19%
-11.51%
Beta (5-Year)
1.512
0.971
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$11.76
200-day SMA
Sell
Level
$11.91
Bollinger Bands (100)
Sell
Level
11.74 - 13.64
Chaikin Money Flow
Sell
Level
-62.9M
20-day SMA
Sell
Level
$12.65
Relative Strength Index (RSI14)
Sell
Level
26.33
ADX Line
Sell
Level
30.96
Williams %R
Buy
Level
-92.5926
50-day SMA
Sell
Level
$12.87
MACD (12, 26)
Sell
Level
-0.50
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-6.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7256)
Sell
CA Score
(Annual)
Level (-0.8231)
Buy
Beneish M-Score
(Annual)
Level (-2.6278)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2838)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Colombia, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
Stock Forecast FAQ
In the current month, SBH has received 0 Buy ratings 3 Hold ratings, and 1 Sell ratings. The SBH average analyst price target in the past 3 months is $12.00.
-
Where Will Sally Beauty Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sally Beauty Holdings share price will rise to $12.00 per share over the next 12 months.
-
What Do Analysts Say About Sally Beauty Holdings?
Analysts are divided on their view about Sally Beauty Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Sally Beauty Holdings is a Buy and believe this share price will drop from its current level to $16.00.
-
What Is Sally Beauty Holdings's Price Target?
The price target for Sally Beauty Holdings over the next 1-year time period is forecast to be $12.00 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is SBH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sally Beauty Holdings is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SBH?
You can purchase shares of Sally Beauty Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sally Beauty Holdings shares.
-
What Is The Sally Beauty Holdings Share Price Today?
Sally Beauty Holdings was last trading at $10.84 per share. This represents the most recent stock quote for Sally Beauty Holdings. Yesterday, Sally Beauty Holdings closed at $11.18 per share.
-
How To Buy Sally Beauty Holdings Stock Online?
In order to purchase Sally Beauty Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
